Clinical Trials Browser

Phase 2 × Neoplasms, Germ Cell and Embryonal × Bevacizumab × Clear all

NCT02988843 2020-12-10

Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors

Phase 2 Terminated

1 enrolled 8 charts

Neoplasms, Germ Cell and Embryonal

NCT00393861 2016-03-24

Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients

Phase 2 Completed

29 enrolled 10 charts

Neoplasms, Germ Cell and Embryonal